Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

2.690
+0.0602.28%
Volume:296.00K
Turnover:787.49K
Market Cap:1.66B
PE:-5.66
High:2.710
Open:2.630
Low:2.620
Close:2.630
52wk High:5.830
52wk Low:2.300
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:1.02
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.475
ROE:-242.61%
ROA:-18.75%
PB:-105.53
PE(LYR):-5.66
PS:- -

Loading ...

Frontier Biotechnologies, a Sub-¥8 Billion Market Cap Biopharma, Plummets to Become A-Shares' Biggest Loser

Deep News
·
Feb 25

CMS Receives NMPA Acceptance and Priority Review for Ruxolitinib Cream's Atopic Dermatitis Application

Stock News
·
Feb 24

Hengrui Pharma's Novel Drug SHR-1918 Injection Receives Marketing Application Acceptance and Priority Review Status

Stock News
·
Feb 24

Domestic Innovative Drug BD Transaction Value Ranks First Globally, This ETF Secures Early Position

Deep News
·
Feb 24

IMMUNOTECH-B Finalizes Issuance of New Convertible Bonds and Notes

Deep News
·
Feb 16

China's Innovative Drug Sector Poised for Global Leap in 2026, Says Senrui Investment Chairman

Deep News
·
Feb 15

IMMUNOTECH-B Finalizes Issuance of New Convertible Bonds and Notes

Stock News
·
Feb 13

Immunotech Biopharm Ltd (6978) Completes RMB270.00 Million New Convertible Bonds Issue and Settles 2023 Convertible Bonds

Bulletin Express
·
Feb 13

Immunotech Biopharm Completes RMB300 Million Convertible Bond Issuance

Reuters
·
Feb 13

Pharmaceutical Firms Flock to Hong Kong for Listings in 2025

Deep News
·
Feb 13

Beijing Promotes Negotiated Pricing Between Insurers and Pharmaceutical Firms to Accelerate Commercial Health Insurance Drug Formulary Implementation

Deep News
·
Feb 12

Hengrui Pharma's Innovative Drug HRS-5346 for Elevated Lipoprotein(a) Levels Added to Breakthrough Therapy List

Deep News
·
Feb 12

HuaShang Fund's Sun Wei: China's Innovative Drug Sector Gains Global Prominence, May Drive Industry-Wide Recovery

Deep News
·
Feb 12

Guosen Securities Highlights Undervalued Healthcare Services and Consumer Sectors with Earnings Recovery Potential

Stock News
·
Feb 12

HuaShang Fund's Zhang Xiao: Clinical Data Narrative Replaces BD Storytelling, Driving Domestic Innovative Drug Development

Deep News
·
Feb 11

Hong Kong Stocks Lead Biotech Rebound as 520880 Surges Nearly 4% on Heavy Volume; Byte's Seedance2.0 Goes Viral; AI and Chip ETFs Rally

Deep News
·
Feb 10

Breakthroughs in Overseas Partnerships and Financial Performance Drive Hong Kong-Listed Innovative Drug Stocks' Rally, ETF 520880 Surges 3.86% on Heavy Volume

Deep News
·
Feb 10

Huasheng Fund Manager Liu Li Identifies Three Key Investment Sectors for 2026

Deep News
·
Feb 10

Biopharmaceutical Stocks Show Broad Gains with CSPC PHARMA Leading with Over 7% Rise

Deep News
·
Feb 10

CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound

Stock News
·
Feb 10